Calcification model, blood vessel model, and test system

The calcification model and blood vessel model with a test system effectively address the challenge of evaluating treatment devices for calcified coronary artery lesions by simulating eccentric lesions and stenosis, enabling quantitative assessment and device selection, thereby improving treatment outcomes.

WO2024232083A1PCT designated stage expired Publication Date: 2024-11-14WASEDA UNIV
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2023/017749
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-05-11
Publication Date
2024-11-14

AI Technical Summary

Technical Problem

Current methods for treating calcified coronary artery lesions, such as balloon dilation and atherectomy, face challenges in effectively evaluating and selecting appropriate treatment devices due to the varied morphology of lesions, particularly eccentric lesions and those located at vessel bends, which can lead to poor device passage and increased risk of blood vessel perforation.

Method used

A calcification model incorporating gypsum to simulate eccentric calcified lesions, a blood vessel model with simulated stenosis, and a test system that allows for the evaluation of treatment device performance in vitro, enabling the creation of various lesion forms and visualization of treatment device behavior within a simulated environment.

Benefits of technology

Enables quantitative evaluation of lesion removal or crushing ability, facilitating the selection of appropriate treatment devices and improving treatment efficacy by simulating real-world lesion conditions and allowing for training and evaluation of new devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2023017749_14112024_PF_FP_ABST
    Figure JP2023017749_14112024_PF_FP_ABST
Patent Text Reader

Abstract

A blood vessel model (200) comprises a simulated blood vessel (210) and a calcification model (100). The simulated blood vessel (210) is provided with: a simulated non-lesion part (212) that simulates a non-lesion portion of a blood vessel; and a simulated narrow part (214) that simulates a narrowed bent part having an inside diameter less than that of the non-lesion portion. The calcification model (100) is provided with: a lesion part (102) that is attached to a simulated constriction part (214), the lesion part (102) containing at least gypsum and simulating an eccentric calcified lesion protruding into a blood vessel; and a support part (104) that protrudes toward the opposite side from the lesion part (102) and supports the lesion part (102).
Need to check novelty before this filing date? Find Prior Art

Description

Calcification model, vascular model, and test system

[0001] The present invention relates to a calcification model that simulates a lesion, a blood vessel model incorporating the calcification model, and a test system for evaluating the performance of a treatment device that removes the lesion.

[0002] Treatment methods for calcified coronary artery lesions include balloon dilatation and atherectomy, which involves removing or crushing the calcified lesions. However, because lesion morphology (location, thickness, shape, etc.) varies from patient to patient, it is necessary to select an appropriate treatment device. To achieve this, it is effective to quantitatively evaluate the performance of treatment devices for various lesion morphologies ex vivo. For example, Patent Literature 1 discloses a technique for creating a circumferential (cylindrical) calcification model in which calcified lesions are distributed around the entire blood vessel, and evaluating the balloon dilatation performance of the calcification model.

[0003] Japanese Patent Application Laid-Open No. 2020-190583

[0004] However, unlike circumferential lesions, eccentric lesions concentrated in a portion of the vessel wall are difficult to dilate using a balloon. Furthermore, treating lesions located in curved vessels presents various challenges, such as poor passage of treatment devices and an increased risk of vascular perforation. Therefore, it is becoming increasingly important to evaluate the performance of treatment devices and select the appropriate treatment device.

[0005] The present invention has been made in view of the above-mentioned problems, and aims to provide a calcification model, a vascular model, and a test system that are more useful for evaluating the performance of a therapeutic device for intravascular lesions in vitro.

[0006] The calcification model according to the present invention comprises at least plaster and has a lesion that simulates an eccentric calcified lesion protruding into a blood vessel.

[0007] The vascular model according to the present invention comprises a simulated blood vessel having a simulated non-lesional portion simulating a non-lesional portion of a blood vessel and a simulated stenosis portion simulating a stenosis portion having an inner diameter smaller than that of the non-lesional portion, and the above-mentioned calcification model attached to the simulated stenosis portion.

[0008] The test system of the present invention is a test system for evaluating the performance of a therapeutic device for removing or crushing calcified lesions in a blood vessel, and includes a simulated blood vessel having a simulated non-lesioned portion simulating a non-lesioned portion of the blood vessel and a simulated stenosis portion simulating a stenosis portion with an inner diameter smaller than that of the non-lesioned portion, a calcification model attached to the simulated stenosis portion, comprising at least plaster, and simulating an eccentric calcified lesion protruding into the blood vessel, and a path for the therapeutic device to access the calcification model.

[0009] According to the present invention, it is possible to evaluate the lesion removal ability or lesion fragmentation ability of a treatment device in vitro using a calcification model that mimics an eccentric calcified lesion.

[0010] FIG. 1 is a schematic diagram of a calcification model of this embodiment simulating an eccentric calcified lesion. FIG. 2 is a schematic diagram showing a base used when producing a silicone mold for the calcification model. FIG. 3 is an example of an actually produced silicone mold. FIG. 4 is an example of an actually produced calcification model. FIG. 5 is a schematic diagram of a blood vessel cast in the shape of a coronary artery. FIG. 6 is a schematic diagram of a coronary artery model incorporating the calcification model shown in FIG. 1. FIG. 7 is a schematic diagram of an aortic model. FIG. 8 is a schematic diagram of a test system combining a coronary artery model and an aortic model. FIG. 9 is an overview illustrating an example in which a treatment device is applied to a test system. FIG. 10 is a schematic diagram showing the behavior of a treatment device removing a lesion in a calcification model. FIG. 11 is a schematic diagram of a calcification model in which a calcified lesion is present on the outer diameter side of a bent portion of a blood vessel. FIG. 12 is a schematic diagram for explaining the bending angle of the bent portion. FIG. 13 is a schematic diagram for explaining the radius of curvature of the bent portion.

[0011] Hereinafter, embodiments of the present invention will be described with reference to the drawings. In the following embodiments, the same or similar components are designated by the same reference numerals throughout the drawings. The drawings are schematic, and the relationship between planar dimensions and thickness, and the thickness ratio of each component, differ from the actual ones. Furthermore, it goes without saying that the dimensional relationships and ratios of each component differ between the drawings.

[0012] 1 shows a schematic diagram of a calcification model 100 of this embodiment. The calcification model 100 is made of at least gypsum and includes a lesion 102 simulating an eccentric calcified lesion protruding into a blood vessel 12, and a support part 104 protruding on the opposite side of the lesion 102 to support the lesion 102. In the following embodiment, as shown in FIG. 1 , attention is focused on an eccentric calcified lesion present in a bent part of the blood vessel 12, but an eccentric calcified lesion present in a straight part of the blood vessel 12 may also be targeted.

[0013] Next, the method ((i) to (iii)) for producing the calcification model 100 will be described with reference to FIGS.

[0014] (i) Preparation of a mold for the calcification model First, multiple resin molds (hereinafter referred to as lesion molds) are prepared by printing the shape of the calcification model 100 using a 3D stereolithography printer. Next, as shown in Figure 2, a base 20 having multiple depressions 22 on its surface is prepared, and the base 20 is placed in a plastic case. Figure 2 shows an example of a base 20 having ten depressions 22. Then, a portion of the support portion of each lesion mold (the portion corresponding to the support portion 104 of the calcification model 100) is fitted into each depression 22. In this way, multiple lesion molds are fixedly positioned on the base 20.

[0015] (ii) Preparation of Silicone Mold Next, liquid silicone is poured into a plastic case with multiple lesion molds placed on base 20 to cover each lesion mold. As described above, each lesion mold is fixed in recess 22 of base 20, so the lesion molds will not flow away even when liquid silicone is poured into the plastic case. Here, the silicone used is, for example, a mixture of equal masses of KE-1603-A (agent A) and KE-1603-B (agent B) manufactured by Shin-Etsu Chemical Co., Ltd.

[0016] After removing any air bubbles from the liquid silicone in the plastic case, the liquid silicone is hardened by heating. The hardened silicone is then removed from the plastic case, and the base 20 and each lesion mold embedded in the silicone are removed to obtain a silicone mold of the calcification model 100. Figure 3 shows an example of an actually produced silicone mold.

[0017] (iii) Fabrication of the Calcified Model Next, the calcified model 100 is fabricated using a silicone mold. First, a container (A cup) containing a mixture of polyurethane (base) and gypsum in a fixed ratio, and a container (B cup) containing a mixture of polyurethane (hardener) and gypsum in another fixed ratio, are prepared. Then, the A cup, B cup, and silicone mold are placed in a vacuum degassing machine.

[0018] The polyurethane and gypsum mixture is then stirred in a vacuum degassing machine and vacuum degassed. The silicone mold is then removed from the vacuum degassing machine and heated in an oven at a predetermined temperature (e.g., 70°C) for a predetermined time (e.g., 20 minutes). The silicone mold is then removed from the oven and left at room temperature for a predetermined time (e.g., 1 hour) or more. The hardened model, i.e., the calcified model, is then removed from the silicone mold.

[0019] An example of an actually constructed calcification model is shown in Figure 4. The calcification model shown in Figure 4 mimics an eccentric calcified lesion present in a bent portion of a coronary artery, and is designed so that the maximum stenosis rate is 80%. By changing parameters related to the stenosis rate and shape, calcification models corresponding to various lesion forms can be constructed.

[0020] Next, a method for producing a coronary artery model simulating a coronary artery having a calcified lesion will be described with reference to FIGS. 5 and 6 as an example of a blood vessel model.

[0021] First, as shown in Figure 5, a resin vascular mold 110 is prepared, which is printed in the shape of a coronary artery using a 3D stereolithography printer. The vascular mold 110 comprises a non-lesioned portion 112 having the shape of a non-lesioned portion of a coronary artery, a bent stenotic portion 114 with a smaller diameter than the non-lesioned portion 112, and a connecting portion 116 for connecting to an aortic model (Figure 7) described below. The connecting portion 116 has a larger diameter than the non-lesioned portion 112. Next, a thin layer of liquid glue is applied to the stenotic portion 114 of the vascular mold 110, and the calcification model 100 is attached so that the lesioned portion 102 of the calcification model 100 fits into the stenotic portion 114.

[0022] Next, the same liquid silicone as described above is poured into the acrylic box to a predetermined thickness. After removing any air bubbles from the liquid silicone inside the acrylic box, the liquid silicone is hardened by heating. Next, the vascular mold 110 with the calcification model 100 is placed on top of the hardened silicone. At this time, the vascular mold 110 is placed so that both ends are in contact with the sides of the acrylic box.

[0023] Next, the above-mentioned liquid silicone is further poured into the acrylic box so that the vascular mold 110 with the calcification model 100 is embedded in the liquid silicone. After removing any air bubbles from the liquid silicone, the liquid silicone is hardened by heating.

[0024] The hardened silicone block is then removed from the acrylic box. The vascular cast 110 embedded in the silicone block is then separated by pulling both ends of the vascular cast 110 with a tool such as pliers, and the separated vascular cast 110 is then pulled out from both ends, leaving the calcification model 100 inside. After the vascular cast 110 has been removed, the inside of the silicone block is then washed with water and dried. In this way, a coronary artery model 200 incorporating the calcification model 100 can be obtained, as shown in FIG. 6 .

[0025] The coronary artery model 200 includes a simulated blood vessel 210, which is a cavity in the shape of a coronary artery, within a silicone block. The simulated blood vessel 210 includes a simulated non-lesion portion 212 that simulates a non-lesion portion of a coronary artery, and a simulated stenosis portion 214 that simulates a narrowed, bent portion with a smaller inner diameter than the non-lesion portion. The calcification model 100 is provided in the simulated stenosis portion 214, and one end of the simulated blood vessel 210 is provided with a first connector 216 for connection to an aorta model ( FIG. 7 ), which will be described later. The first connector 216 has a larger inner diameter than the simulated non-lesion portion 212. Because the simulated blood vessel 210 is made of a transparent material such as silicone, it is possible to visualize the behavior of a treatment device within the simulated blood vessel 210, as will be described later.

[0026] The coronary artery model 200 and the calcification model 100 need to be designed in parallel so that the simulated stenosis portion 214 of the simulated blood vessel 210 and the lesion portion 102 of the calcification model 100 fit together.

[0027] Next, a test system for evaluating the performance of a therapeutic device will be described with reference to FIGS.

[0028] First, as shown in FIG. 7 , an aortic model 310 resembling the aorta is created using a 3D stereolithography printer. The aortic model 310 includes a descending aortic section 312, an aortic arch section 314, an ascending aortic section 316, a brachiocephalic artery section 318, and a second connector 320 for connecting to the coronary artery model 200. The outer diameter of the second connector 320 is approximately equal to the inner diameter of the first connector 216 of the coronary artery model 200. While an actual blood vessel has a substantially circular cross section, the aortic model 310 has a semicircular cross section and a flat surface. This flat surface makes it easy to place the aortic model 310 on a flat surface.

[0029] As shown in FIG. 8 , the test system 300 can be constructed by inserting the second connector 320 of the aorta model 310 into the first connector 216 of the coronary artery model 200 and combining the coronary artery model 200 and the aorta model 310.

[0030] To fabricate the actual test system 300, first, as shown in FIG. 9 , an opening 422 for inserting the catheter 412 of the treatment device 410 is formed in the side of a container 420, and the aorta model 310 is fixed to the bottom of the container 420 with adhesive. Then, a liquid 424 is poured into the container 420 to cover the entire aorta model 310. The liquid 424 can be, for example, a glycerin solution. The coronary artery model 200 is then connected to the aorta model 310 in the container 420 to construct the test system 300. The coronary artery model 200 is then filled with the liquid 424 and air bubbles are removed. A camera 430 is installed above the test system 300. The glycerin solution is used here because its refractive index can be matched to that of the silicone of the coronary artery model 200 and its transparency allows visualization of the behavior of the treatment device 410 within the coronary artery model 200.

[0031] 7 and 8 constitute a path for the treatment device 410 to access the calcification model 100 of the coronary artery model 200. The catheter 412 of the treatment device 410 is inserted from the descending aorta section 312 or the brachiocephalic artery section 318 of the aorta model 310 and moves to the lesioned portion 102 of the calcification model 100 via the second connecting portion 320 and the first connecting portion 216. Then, as shown in FIG. 10 , the treatment device 410 is driven at the position of the lesioned portion 102 present in the simulated stenosis portion 214, thereby removing or crushing the lesioned portion 102.

[0032] For example, in an Orbital Atherectomy System (OAS), the lesion 102 of the calcification model 100 can be scraped away by centrifugal force by rotating an eccentric diamond-coated crown attached to the tip of the catheter 412.

[0033] As shown in Figures 6 and 10, the calcification model 100 attached to the bent simulated stenosis section 214 is provided with a support section 104 that protrudes on the side opposite to the lesion section 102, thereby preventing the calcification model 100 from shifting position due to the operation of the treatment device 410.

[0034] As described above, the simulated blood vessel 210 is provided in a transparent member, and the glycerin aqueous solution in the container 420 is also transparent, so that video of the behavior of the treatment device 410 during the evaluation test can be captured by the camera 430. By measuring the resection depth, resection cross-sectional area, resection width, resection volume, etc. of the lesion 102 from the captured data obtained by the camera 430, the lesion removal ability of the treatment device 410 can be quantitatively evaluated ex vivo, and the relationship between the lesion morphology and the lesion removal ability or lesion crushing ability can be grasped.

[0035] Although the above-described calcification model 100 simulates a calcified lesion present on the inner diameter side of a bent portion of a blood vessel 12, the location of the calcified lesion is not limited in this embodiment. As shown in Fig. 11 , a calcification model 100B may be employed that simulates a calcified lesion present on the outer diameter side of a bent portion of a blood vessel 12. The calcification model 100B includes a lesion portion 102B that simulates an eccentric calcified lesion protruding from the outer diameter side of the bent portion of the blood vessel 12, and a support portion 104B that protrudes on the opposite side from the lesion portion 102B and supports the lesion portion 102B.

[0036] Furthermore, as shown in Figures 12 and 13, by arbitrarily changing the bending angle (Figure 12) and curvature radius (Figure 13) of the bending portion of the blood vessel 12, or by arbitrarily changing the stenosis rate of the lesion portion, various calcification models and coronary artery models (blood vessel models) can be produced according to the lesion morphology.

[0037] 8, the coronary artery model 200 is detachable from the aorta model 310. Therefore, by preparing various coronary artery models 200 according to lesion morphology and making them detachable from the aorta model 310, it is possible to perform performance evaluation of the treatment device 410 for various lesion morphologies at low cost.

[0038] The calcification model, vascular model, and test system of this embodiment are not only capable of quantitatively evaluating the effectiveness of existing treatment devices for removing or crushing calcified lesions, but are also useful for training on new treatment devices.

[0039] The present invention is not limited to the above-described embodiment, and various modifications are possible within the scope of the present invention.

[0040] 12 Blood vessel 100, 100B Calcification model 102, 102B Lesioned portion 104, 104B Support portion 110 Blood vessel cast 112 Non-lesioned portion 114 Stenosis portion 200 Coronary artery model (blood vessel model) 210 Simulated blood vessel 212 Simulated non-lesioned portion 214 Simulated stenosis portion 300 Test system 310 Aorta model 410 Treatment device 412 Catheter 430 Camera

Claims

1. A calcification model comprising at least gypsum and having a lesion simulating an eccentric calcified lesion protruding into a blood vessel.

2. The calcification model according to claim 1, wherein the lesion comprises polyurethane and the gypsum.

3. The calcification model according to claim 1, wherein the lesion is a replica of the calcified lesion present in a bent portion of the blood vessel.

4. The calcification model according to claim 1, further comprising a support part protruding on the opposite side to the lesion part and supporting the lesion part.

5. A blood vessel model comprising: a simulated blood vessel having a simulated non-lesioned portion simulating a non-lesioned portion of a blood vessel and a simulated stenosis portion simulating a stenosis portion having an inner diameter smaller than that of the non-lesioned portion; and a calcification model according to any one of claims 1 to 4 attached to the simulated stenosis portion.

6. The blood vessel model according to claim 5, wherein the simulated stenosis portion simulates a stenosed bent portion of the blood vessel.

7. The blood vessel model according to claim 5, wherein the simulated blood vessel is a blood vessel-shaped cavity provided in a transparent member.

8. A test system for evaluating the performance of a therapeutic device for removing or crushing calcified lesions in a blood vessel, comprising: a simulated blood vessel having a simulated non-lesioned portion simulating a non-lesioned portion of the blood vessel and a simulated stenosis portion simulating a stenosis portion having an inner diameter smaller than that of the non-lesioned portion; a calcification model attached to the simulated stenosis portion, comprising at least gypsum, simulating an eccentric calcified lesion protruding into the blood vessel; and a path for the therapeutic device to access the calcification model.

9. The test system of claim 8, wherein the calcification model comprises polyurethane and the gypsum.

10. The test system of claim 8, wherein a vascular model is formed from the simulated blood vessel and the calcification model, the pathway forms an aortic model simulating the aorta, one end of the simulated blood vessel of the vascular model is provided with a first connection part for connecting to the aortic model, and the aortic model is provided with a second connection part for connecting to the vascular model, and the vascular model and the aortic model are combined via the first connection part and the second connection part.

11. The test system of claim 10, wherein the blood vessel model is detachable from the aorta model.

12. The test system of claim 10, wherein the aortic model has a descending aortic section and a brachiocephalic artery section, and the pathway for the treatment device to access the calcification model from the descending aortic section or the brachiocephalic artery section constitutes the test system.

13. The test system of claim 10, wherein the pathway constituting the aorta model is semicircular in cross section and has flat surfaces.

Citation Information

Patent Citations

  • Simulated blood vessel for atherosclerosis lesion, its production method, ultrasonic phantom, test device for verifying blood flow numerical analysis and simulated blood vessel for evaluation test for percutaneous transluminal coronary angioplasty

    JP2004275682A

  • Simulated constriction blood vessel and manufacturing method thereof

    JP2010224069A

  • Biological model for training and method of manufacturing the same

    JP2011027795A

  • Stenosis model and training kit

    JP2012220728A

  • Calcification lesion model and its manufacturing method as well as test method of medical instrument

    JP2020190583A